PTEN and neoplasm: To further validate the molecular basis, we then performed immunohischemistry on the tumor xenografts to detect the level of proliferation marker Ki67, EMT-related vimentin, apoptosis-related caspase 3 and the Akt signaling inhibitor PTEN in vivo.